Journal article · 2011 · Open access
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
ACS Chemical Neuroscience, 3(1), 50–68 · Published 2 November 2011 · DOI 10.1021/cn200100h
In brief
“Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery” is a 2011 journal article by Arup K. Ghose and 4 co-authors, published in ACS Chemical Neuroscience. OpenAlex counts 468 citations as of 15 November 2026, which puts it in the top 1% of works published in 2011 by citations. It is open access: the full text is free to read at ACS Chemical Neuroscience.
- Citations
- 468
- Most cited in
- 2019 (47)
- Field-weighted impact
- 6.64
- References
- 48
- Authors
- 5
Abstract
The central nervous system (CNS) is the major area that is affected by aging. Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment. Achievement of appropriate blood-brain barrier (BBB) penetration is often considered a significant hurdle in the CNS drug discovery process. On the other hand, BBB penetration may be a liability for many of the non-CNS drug targets, and a clear understanding of the physicochemical and structural differences between CNS and non-CNS drugs may assist both research areas. Because of the numerous and challenging issues in CNS drug discovery and the low success rates, pharmaceutical companies are beginning to deprioritize their drug discovery efforts in the CNS arena. Prompted by these challenges and to aid in the design of high-quality, efficacious CNS compounds, we analyzed the physicochemical property and the chemical structural profiles of 317 CNS and 626 non-CNS oral drugs. The conclusions derived provide an ideal property profile for lead selection and the property modification strategy during the lead optimization process. A list of substructural units that may be useful for CNS drug design was also provided here. A classification tree was also developed to differentiate between CNS drugs and non-CNS oral drugs. The combined analysis provided the following guidelines for designing high-quality CNS drugs: (i) topological molecular polar surface area of <76 Å(2) (25-60 Å(2)), (ii) at least one (one or two, including one aliphatic amine) nitrogen, (iii) fewer than seven (two to four) linear chains outside of rings, (iv) fewer than three (zero or one) polar hydrogen atoms, (v) volume of 740-970 Å(3), (vi) solvent accessible surface area of 460-580 Å(2), and (vii) positive QikProp parameter CNS. The ranges within parentheses may be used during lead optimization. One violation to this proposed profile may be acceptable. The chemoinformatics approaches for graphically analyzing multiple properties efficiently are presented.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2011). Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/10.1021/cn200100h
MLA 9
Ghose, Arup K., et al. “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery.” ACS Chemical Neuroscience, vol. 3, no. 1, 2011, pp. 50–68. https://doi.org/10.1021/cn200100h.
Chicago
Ghose, Arup K., Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, and John P. Mallamo. 2011. “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery.” ACS Chemical Neuroscience 3 (1): 50–68. https://doi.org/10.1021/cn200100h.
Harvard
Ghose, A. K. et al. (2011) ‘Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery’, ACS Chemical Neuroscience, 3(1), pp. 50–68. doi:10.1021/cn200100h.
IEEE
A. K. Ghose, T. Herbertz, R. L. Hudkins, B. D. Dorsey, and J. P. Mallamo, “Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery,” ACS Chemical Neuroscience, vol. 3, no. 1, pp. 50–68, 2011, doi: 10.1021/cn200100h.
BibTeX
@article{ghose2011knowledge,
title = {{Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery}},
author = {Ghose, Arup K. and Herbertz, Torsten and Hudkins, Robert L. and Dorsey, Bruce D. and Mallamo, John P.},
journal = {ACS Chemical Neuroscience},
year = {2011},
volume = {3},
number = {1},
pages = {50--68},
doi = {10.1021/cn200100h},
url = {https://doi.org/10.1021/cn200100h}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 25 | |
| 2018 | 42 | |
| 2019 | 47 | |
| 2020 | 27 | |
| 2021 | 35 | |
| 2022 | 40 | |
| 2023 | 33 | |
| 2024 | 42 | |
| 2025 | 40 | |
| 2026 | 36 |
Its field-weighted citation impact is 6.64: it has been cited 6.64 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- CNS drug discovery
- blood-brain barrier penetration
- lead selection
- lead optimization
- physicochemical properties
- structure-property relationships
- classification trees
- polar surface area
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2011). Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/10.1021/cn200100h
How many times has this paper been cited?
468 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at ACS Chemical Neuroscience.
Who wrote this paper?
Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey, John P. Mallamo.
What is the DOI of this paper?
10.1021/cn200100h. The permanent link is https://doi.org/10.1021/cn200100h.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.